BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21078541)

  • 1. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
    Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
    Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-neoplastic effects of fucoxanthin and its deacetylated product, fucoxanthinol, on Burkitt's and Hodgkin's lymphoma cells.
    Tafuku S; Ishikawa C; Yasumoto T; Mori N
    Oncol Rep; 2012 Oct; 28(4):1512-8. PubMed ID: 22859062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-adult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol.
    Ishikawa C; Tafuku S; Kadekaru T; Sawada S; Tomita M; Okudaira T; Nakazato T; Toda T; Uchihara JN; Taira N; Ohshiro K; Yasumoto T; Ohta T; Mori N
    Int J Cancer; 2008 Dec; 123(11):2702-12. PubMed ID: 18798263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effects of marine carotenoids, fucoxanthin and its deacetylated product, fucoxanthinol, on osteosarcoma.
    Rokkaku T; Kimura R; Ishikawa C; Yasumoto T; Senba M; Kanaya F; Mori N
    Int J Oncol; 2013 Oct; 43(4):1176-86. PubMed ID: 23857515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231.
    Rwigemera A; Mamelona J; Martin LJ
    Anticancer Res; 2015 Jan; 35(1):207-19. PubMed ID: 25550553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment.
    Martin LJ
    Mar Drugs; 2015 Jul; 13(8):4784-98. PubMed ID: 26264004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells.
    Konishi I; Hosokawa M; Sashima T; Kobayashi H; Miyashita K
    Comp Biochem Physiol C Toxicol Pharmacol; 2006; 142(1-2):53-9. PubMed ID: 16337836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells.
    Hussain AR; Al-Jomah NA; Siraj AK; Manogaran P; Al-Hussein K; Abubaker J; Platanias LC; Al-Kuraya KS; Uddin S
    Cancer Res; 2007 Apr; 67(8):3888-97. PubMed ID: 17440103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway.
    Rwigemera A; Mamelona J; Martin LJ
    Cell Biol Toxicol; 2014 Jun; 30(3):157-67. PubMed ID: 24760606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Biological Functions of a Cytoprotective Effect and Apoptosis Induction by Bioavailable Marine Carotenoid Fucoxanthinol through Modulation of the Nrf2 Activation in RAW264.7 Macrophage Cells.
    Taira J; Sonamoto M; Uehara M
    Mar Drugs; 2017 Oct; 15(10):. PubMed ID: 28984834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin disrupts the latency of human herpesvirus 8 and induces apoptosis in primary effusion lymphoma cells.
    Wang YF; Chiou YH; Wang LY; Chang ST; Shyu HW; Chen CY; Lin KH; Chou MC
    Cancer Invest; 2012 May; 30(4):268-74. PubMed ID: 22480174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.
    Maeda H; Kanno S; Kodate M; Hosokawa M; Miyashita K
    Mar Drugs; 2015 Aug; 13(8):4799-813. PubMed ID: 26248075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
    Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S
    Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites.
    Asai A; Sugawara T; Ono H; Nagao A
    Drug Metab Dispos; 2004 Feb; 32(2):205-11. PubMed ID: 14744942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent reactive oxygen species-JNK-p38 activation by sodium salicylate potentiates death of primary effusion lymphoma cells.
    Vaeteewoottacharn K; Mitchai M; Srikoon P; Hattori S; Kariya R; Matsuda K; Wongkham S; Okada S
    Anticancer Res; 2014 Apr; 34(4):1865-71. PubMed ID: 24692721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
    Maeda H; Hosokawa M; Sashima T; Takahashi N; Kawada T; Miyashita K
    Int J Mol Med; 2006 Jul; 18(1):147-52. PubMed ID: 16786166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin induces apoptosis in YD-8 human oral squamous carcinoma cells through activation of caspases, down-regulation of Mcl-1, and inactivation of ERK-1/2 and AKT.
    Park IS; Jo JR; Hong H; Nam KY; Kim JB; Hwang SH; Choi MS; Ryu NH; Jang HJ; Lee SH; Kim CS; Kwon TG; Park GY; Park JW; Jang BC
    Toxicol In Vitro; 2010 Apr; 24(3):713-20. PubMed ID: 20116423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells.
    Kotake-Nara E; Asai A; Nagao A
    Cancer Lett; 2005 Mar; 220(1):75-84. PubMed ID: 15737690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
    Terasaki M; Takahashi S; Nishimura R; Kubota A; Kojima H; Ohta T; Hamada J; Kuramitsu Y; Maeda H; Miyashita K; Takahashi M; Mutoh M
    Nutr Cancer; 2022; 74(1):357-371. PubMed ID: 33590779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.